Active substance
Albumin human
- SFDA 34
- US FDA 1
- Safety 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| ALBUTEIN 20% SOLN. FOR INJ | 20 % | Intravenous infusion · Intravenous use | 1 Vial | SAR 146.40 | Biological · Prescription | GRIFOLS BIOLOGICALS LLC | Valid |
| Albumin SK | 20 % | Solution for injection · Intravenous use | 1 Vial | SAR 164.45 | Biological · Prescription | SK Plasma Co. Ltd | Valid |
| Albumin SK | 20 % | Solution for injection · Intravenous use | 1 Vial | SAR 314.60 | Biological · Prescription | SK Plasma Co. Ltd | Valid |
| Alburex | 200 g/l | Solution · Intravenous use | 1 Vial | SAR 249.10 | Biological · Prescription | CSL BEHRING | Valid |
| Alburex | 200 g/l | Solution · Intravenous use | 1 Vial | SAR 154.95 | Biological · Prescription | CSL BEHRING | Valid |
| FLEXBUMIN 200GM/L SOLUTION FOR INFUSION | 200 g/l | Solution for infusion · Intravenous use | 1 Bag | SAR 156.55 | Biological · Prescription | Takeda Manufacturing AG | Valid |
| FLEXBUMIN 200GM/L SOLUTION FOR INFUSION | 200 g/l | Solution for infusion · Intravenous use | 1 Bag | SAR 285.85 | Biological · Prescription | Takeda Manufacturing AG | Valid |
| HUMAN ALBUMIN 20% | 20 % | Solution · Intravenous use | 1 Vial | SAR 146.40 | Biological · Prescription | OCTAPHARMA | Valid |
| HUMAN ALBUMIN 20% | 20 % | Solution · Intravenous use | 1 Bottle | SAR 213.85 | Biological · Prescription | OCTAPHARMA | Valid |
| HUMAN ALBUMIN 20% +INFUSION SET | 20 % | Solution · Intravenous use | 1 Vial | SAR 138.55 | Biological · Prescription | BIOTEST | Valid |
| HUMAN ALBUMIN 20% +INFUSION SET | 20 % | Solution · Intravenous use | 1 Bottle | SAR 262.90 | Biological · Prescription | BIOTEST | Valid |
| HUMAN ALBUMIN 20% SOLUTION FOR INFUSION | 20 % | Solution · Intravenous use | 1 Vial | SAR 164.45 | Biological · Prescription | HUMAN BioPlazma LLC | Valid |
| HUMAN ALBUMIN 20% SOLUTION FOR INFUSION | 20 % | Solution · Intravenous use | 1 Vial | SAR 314.60 | Biological · Prescription | HUMAN BioPlazma LLC | Valid |
| HUMAN ALBUMIN 200G-I TAKEDA | 20 % | Solution · Intravenous use | 1 Vial | SAR 141.00 | Biological · Prescription | Takeda Manufacturing AG | Valid |
| HUMAN ALBUMIN 5% | 5 % | Solution · Intravenous use | 1 Bottle | SAR 187.05 | Biological · Prescription | OCTAPHARMA | Valid |
| HUMAN ALBUMIN 5% | 5 % | Solution · Intravenous use | 1 Bottle | SAR 190.60 | Biological · Prescription | BIOTEST | Valid |
| HUMAN ALBUMIN 50G-I TAKEDA 250ML | 5 % | Solution · Intravenous use | 1 Bottle | SAR 209.55 | Biological · Prescription | Takeda Manufacturing AG | Valid |
| Human Albumin Grifols 20% | 20 % | Solution for infusion · Intravenous use | 1 Vial | SAR 213.85 | Biological · Prescription | Instituto Grifols, S.A | Valid |
| Human Albumin Grifols 20% | 20 % | Solution for infusion · Intravenous use | 1 Vial | SAR 146.40 | Biological · Prescription | Instituto Grifols, S.A | Valid |
| PLASBUMIN 20% | 20 % | Suspension for injection · Intravenous use | 1 Vial | SAR 146.40 | Biological · Prescription | GRIFOLS THERAPEUTICS INC | Valid |
| PLASBUMIN 20% | 20 % | Suspension for injection · Intravenous use | 1 Vial | SAR 213.85 | Biological · Prescription | GRIFOLS THERAPEUTICS INC | Valid |
| UMAN ALBUMIN 20% SOLUTION FOR INFUSION | 20 % | Solution · Intravenous use | 1 Vial | SAR 122.75 | Biological · Prescription | KEDRION | Valid |
| UMAN ALBUMIN 20% SOLUTION FOR INFUSION | 20 % | Solution · Intravenous use | 1 Bottle | SAR 245.50 | Biological · Prescription | KEDRION | Valid |
| ALBUMINATIVE 20% I.V. | 20 % | Solution · Intravenous use | 1 Vial | SAR 215.25 | Biological · Prescription | OCTAPHARMA | Withdrawn by MAH · Not Marketed |
| ALBUMINATIVE 20% I.V. | 20 % | Solution · Intravenous use | 1 Bottle | SAR 300.70 | Biological · Prescription | OCTAPHARMA | Withdrawn by MAH · Not Marketed |
9 more — full table
Indications — CHI Daman Drug Formulary
BURN MANAGEMENT; LIVER CIRRHOSIS; Septic Shock
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| OPTISON | 10MG/ML | injectable · injection | GE HEALTHCARE | Prescription | 31 Dec 1997 |
Safety signals and safety-related labeling changes
- US FDA 9 May 2025 OPTISON — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Use in Specific Populations
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.